The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

Cassandra Smith has rheumatoid arthritis (RA) and knows all too well how debilitating the autoimmune condition can be. Her ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...

The 23-time Grand Slam champion recently opened up to PEOPLE exclusively about using a GLP-1 medication to help with weight ...

Serena Williams finally comes clean about her drastic weight change. She shares she lost 31 pounds through weight loss ...

Serena Williams shares she is now using a GLP-1 in partnership with Ro, a digital health care company. Find out why she’s not ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.